These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35812829)

  • 1. Prescribing patterns of long-acting injectable antipsychotics in a community setting in South Africa.
    Veyej N; Moosa MYH
    S Afr J Psychiatr; 2022; 28():1809. PubMed ID: 35812829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination Therapy of Long-Acting Injectable Second-Generation Antipsychotics and Oral Antipsychotics: A Retrospective Chart Review and Prescribers' Attitude Survey.
    Misawa F; Amemiya A; Fujii Y; Takeuchi H
    J Clin Psychopharmacol; 2022 Jan-Feb 01; 42(1):81-86. PubMed ID: 34668878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis.
    Medrano S; Abdel-Baki A; Stip E; Potvin S
    Psychopharmacol Bull; 2018 Jun; 48(4):25-61. PubMed ID: 30618474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting antipsychotic treatments: focus on women with schizophrenia.
    Brissos S; Balanzá-Martínez V
    Ther Adv Psychopharmacol; 2024; 14():20451253241263715. PubMed ID: 39091697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment patterns and health care resource utilization in a 1-year observational cohort study of outpatients with schizophrenia at risk of nonadherence treated with long-acting injectable antipsychotics.
    Bernardo M; San L; Olivares JM; Dilla T; Polavieja P; Gilaberte I; Alvarez M; Ciudad A
    Patient Prefer Adherence; 2011; 5():601-10. PubMed ID: 22259237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Acting Injectable Antipsychotics in the Geriatric Population: A longitudinal Study.
    Mosharraf N; Estevez TP; Cohen LJ; Lantz M
    Am J Geriatr Psychiatry; 2024 Jul; ():. PubMed ID: 39013751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
    Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
    PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.
    Doshi JA; Pettit AR; Stoddard JJ; Zummo J; Marcus SC
    J Clin Psychopharmacol; 2015 Aug; 35(4):442-6. PubMed ID: 26075492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic.
    Pilon D; Joshi K; Tandon N; Lafeuille MH; Kamstra RL; Emond B; Lefebvre P
    Patient Prefer Adherence; 2017; 11():619-629. PubMed ID: 28356723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attitude and preferences towards oral and long-acting injectable antipsychotics in patients with psychosis in KwaZulu-Natal, South Africa.
    Roopun KR; Tomita A; Paruk S
    S Afr J Psychiatr; 2020; 26():1509. PubMed ID: 32832130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of switching to long-acting injectable antipsychotics on health services use in the treatment of schizophrenia.
    Lachaine J; Lapierre ME; Abdalla N; Rouleau A; Stip E
    Can J Psychiatry; 2015 Mar; 60(3 Suppl 2):S40-7. PubMed ID: 25886679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective study of psychotropic drug use among individuals with mental illness issued a community treatment order.
    Gisev N; Bell JS; Chen TF
    Int J Clin Pract; 2014 Feb; 68(2):236-44. PubMed ID: 24372715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes of European physicians towards the use of long-acting injectable antipsychotics.
    Patel MX; Bent-Ennakhil N; Sapin C; di Nicola S; Loze JY; Nylander AG; Heres S
    BMC Psychiatry; 2020 Mar; 20(1):123. PubMed ID: 32169077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Outcomes in Nonacute Patients With Schizophrenia Treated With Long-Acting Injectable Antipsychotics Versus Oral Antipsychotics.
    Petric PS; Teodorescu A; Miron AA; Manea MC; Ifteni P
    Am J Ther; 2024 May-Jun 01; 31(3):e219-e228. PubMed ID: 38691662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia.
    Kishi T; Sakuma K; Okuya M; Iwata N
    J Psychiatr Res; 2021 Jan; 132():144-150. PubMed ID: 33096355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninterventional, Naturalistic, Retrospective Study to Describe Prescription Patterns of Long-Acting Injectable Antipsychotics and the Impact of Introducing a New Atypical Antipsychotic in the Spanish Province of Tarragona Catchment Area.
    Gaviria AM; Franco J; Rico G; Muntané G; Sáez C; Sánchez-Gistau V; de Pablo J; Vilella E
    Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28346773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study.
    Joo SW; Shon SH; Choi G; Koh M; Cho SW; Lee J
    Eur Neuropsychopharmacol; 2019 Sep; 29(9):1051-1060. PubMed ID: 31362852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oral antipsychotic supplementation of select second-generation long-acting injectable antipsychotics in an acute-care psychiatric setting.
    Alastanos JN; Paxos C; Emshoff J
    Ment Health Clin; 2019 Jan; 9(1):18-23. PubMed ID: 30627499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-World Utilization Patterns of Long-Acting Injectable Antipsychotics in Canada: A Retrospective Study.
    Agid O; Remington G; Fung C; Nightingale NM; Duclos M; Anger GJ
    Can J Psychiatry; 2022 Mar; 67(3):226-234. PubMed ID: 34792401
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.